REYATAZ is a prescription medicine used in combination with other medicines to treat people 6 years of age and older who are infected with the human immunodeficiency virus (HIV). REYATAZ has been studied in a 48-week trial in patients who have taken anti-HIV medicines and a 96-week trial in patients who have never taken anti-HIV medicines.
REYATAZ does not cure HIV or lower your chance of passing HIV to others. People taking
REYATAZ may still get opportunistic infections or other conditions that happen with HIV infection.
Selected Important Safety Information:
Do not take REYATAZ if you are allergic to REYATAZ or to any of its ingredients.
Do not take REYATAZ if you are taking certain medications due to potential for serious, life-threatening side effects or death.
Read more REYATAZ Important Safety Information.